The Prognostic Significance of the Preoperative Platelet-Lymphocyte Ratio in Japanese Patients with Localized Breast Cancer

ISSN Print: 2168-1589
ISSN Online: 2168-1597
www.scirp.org/journal/abcr
E-mail: abcr@scirp.org

Citations h5-index & Ranking*

"The Prognostic Significance of the Preoperative Platelet-Lymphocyte Ratio in Japanese Patients with Localized Breast Cancer"
written by Hideya Takeuchi, Seiichi Fukuyama, Nobuhide Kubo, Shoji Hiroshige, Hirofumi Kawanaka, Yasuji Yoshikawa, Tokujiro Yano,
published by Advances in Breast Cancer Research, Vol.5 No.2, 2016

has been cited by the following article(s):

[1]	Platelet-to-Lymphocyte Ratio and CA125 Level as a Combined Biomarker for Diagnosing Endometriosis and Predicting Pelvic Adhesion Severity
	Frontiers in Oncology, 2022

[2]	Significance of Red Cell Distribution Width to Platelet Count Ratio (RPR) in Patients with Breast Cancer
	European Journal of Molecular & …, 2022

[3]	Prognostic value of pre-treatment routine hematological parameters in breast carcinoma: Advantageous or deleterious?
	2020

[4]	Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer
	2020

[5]	Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer
	2020

[6]	Pretreatment platelet to lymphocyte ratio is associated with breast cancer prognosis: an updated meta-analysis
	2019

[7]	Three gold indicators for breast cancer prognosis: a case–control study with ROC analysis for novel ratios related to CBC with (ALP and LDH)
	2019

[8]	Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer
	2019

[9]	Does Platelet Mass Index Play a Role in Predicting Biochemical Recurrence in Localized Prostate Cancer?
	2018

[10]	Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer
	PLOS ONE, 2017

[11]	The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer
	PLOS ONE, 2017

[1]	Platelet-to-Lymphocyte Ratio and CA125 Level as a Combined Biomarker for Diagnosing Endometriosis and Predicting Pelvic Adhesion Severity Frontiers in Oncology, 2022 DOI:10.3389/fonc.2022.896152

[2]	Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer BMC Urology, 2020 DOI:10.1186/s12894-020-00628-z

[3]	Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer Scientific Reports, 2019 DOI:10.1038/s41598-019-40024-8

[4]	Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer Scientific Reports, 2019 DOI:10.1038/s41598-019-40024-8

[5]	Three gold indicators for breast cancer prognosis: a case–control study with ROC analysis for novel ratios related to CBC with (ALP and LDH) Molecular Biology Reports, 2019 DOI:10.1007/s11033-019-04650-9

[6]	Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer Scientific Reports, 2019 DOI:10.1038/s41598-019-40024-8

[7]	Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer PLOS ONE, 2017 DOI:10.1371/journal.pone.0177137

[8]	The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer PLOS ONE, 2017 DOI:10.1371/journal.pone.0189166